Vitasora Health Limited (ASX:VHL)
Australia · Delayed Price · Currency is AUD 0.0140
+0.0010 (7.69%)
Sep 9, 2026, 3:44 PM AEST
Vitasora Health Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 4.29 | 3.09 | 0.46 | 0.07 | 0.25 |
Other Revenue | 0.55 | 0.61 | 0.58 | 0.59 | 0.52 |
| 4.84 | 3.71 | 1.04 | 0.66 | 0.77 | |
Revenue Growth | 30.63% | 256.78% | 56.85% | -14.26% | -44.29% |
Cost of Revenue | 0.58 | 0.17 | 0 | 0.07 | 0.26 |
Gross Profit | 4.26 | 3.53 | 1.03 | 0.6 | 0.51 |
Selling, General & Admin | 13.23 | 12.17 | 7.36 | 5.57 | 5.29 |
Research & Development | 0.38 | 0.24 | 0.14 | 0.38 | 1.46 |
Operating Expenses | 14.87 | 14.24 | 8.1 | 6.36 | 7.14 |
Operating Income | -10.61 | -10.7 | -7.06 | -5.76 | -6.63 |
Interest Expense | - | - | -0.07 | -0.02 | - |
Interest & Investment Income | - | - | - | - | 0.01 |
Pretax Income | -10.61 | -10.7 | -7.13 | -5.78 | -6.62 |
Income Tax Expense | - | 0 | - | - | - |
Net Income | -10.61 | -10.7 | -7.13 | -5.78 | -6.62 |
Net Income to Common | -10.61 | -10.7 | -7.13 | -5.78 | -6.62 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 1,840 | 1,396 | 1,018 | 806 | 729 |
Shares Outstanding (Diluted) | 1,840 | 1,396 | 1,018 | 806 | 729 |
Shares Change | 31.80% | 37.16% | 26.19% | 10.68% | 4.23% |
EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -10 | -9.17 | -6.64 | -4.51 | -8.48 |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Gross Margin | 88.02% | 95.40% | 99.63% | 90.09% | 66.42% |
Operating Margin | -219.22% | -288.81% | -680.22% | -870.00% | -858.74% |
Profit Margin | -219.22% | -288.85% | -686.48% | -872.26% | -857.85% |
Free Cash Flow Margin | -206.68% | -247.43% | -639.50% | -681.46% | -1098.15% |
EBITDA | -9.36 | -10.04 | -7 | -5.75 | -6.62 |
EBITDA Margin | -193.34% | -271.09% | - | - | - |
D&A For EBITDA | 1.25 | 0.66 | 0.06 | 0.01 | 0.02 |
EBIT | -10.61 | -10.7 | -7.06 | -5.76 | -6.63 |
EBIT Margin | -219.22% | -288.81% | - | - | - |
Revenue as Reported | 4.84 | 3.71 | 1.04 | 0.66 | 0.78 |